What is NovoCure's asset turnover?

NovoCure (NVCR) reported asset turnover of 0.7× in Q1 2026.

How has NovoCure's asset turnover changed year-over-year?

NovoCure's asset turnover increased by 26.2% year-over-year, from 0.5× to 0.7×.

What is the long-term trend for NovoCure's asset turnover?

Over 5 years (2020 to 2025), NovoCure's asset turnover has grown at a -0.1% compound annual growth rate (CAGR), from 0.6× to 0.6×.

What does asset turnover mean?

Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

NovoCure NVCR Asset turnover

Asset turnover at other companies

Boston ScientificBSX

0.5×0.0×

MedtronicMDT

0.4×0.0×

Iovance Biotherapeutics, Inc.IOVA

0.3×+0.1×

Nuvation BioNUVB

0.3×+0.2×

Vir Biotechnology, Inc.VIR

0.1×0.0×

Syndax PharmaceuticalsSNDX

0.4×+0.3×

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.64B-36.7%

Enterprise value$1.59B-36.3%

P/S2.4×-1.7×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

total revenue/total assets=0.7×

Based on trailing twelve months.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's asset turnover?: NovoCure (NVCR) reported asset turnover of 0.7× in Q1 2026.
How has NovoCure's asset turnover changed year-over-year?: NovoCure's asset turnover increased by 26.2% year-over-year, from 0.5× to 0.7×.
What is the long-term trend for NovoCure's asset turnover?: Over 5 years (2020 to 2025), NovoCure's asset turnover has grown at a -0.1% compound annual growth rate (CAGR), from 0.6× to 0.6×.
What does asset turnover mean?: Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.